Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 1, 1998, Pages 90-93

  Picquet, Michel ^a,b   Vercruysse, Jozef ^b   Shaw, Darren J ^b   Diop, Mamadou ^a   Ly, Abdoulaye ^a  

^a Programme ESPOIR   (Senegal)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Chemotherapy; Praziquantel; Schistosoma mansoni; Schistosomiasis; Senegal

Indexed keywords

ANTITREMATODAL AGENT; PRAZIQUANTEL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHOOL CHILD; SENEGAL;

SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TREMATODA;

EID: 0031883522     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)90971-3     Document Type: Article

References (29)

1. Andrews, P. (1981). Preclinical data of praziquantel. A summary of the efficacy of praziquantel against schistosomes in animal experiments and notes on its mode of action. Arzneimittel-Forschung, 31, 538-541.
2. Andrews, P. (1985). Praziquantel: mechanisms of anti-schistosomal activity. Pharmacology and Therapeutics, 29, 129-156.
3. Brindley, P. J. & Sher, A. (1987). The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. Journal of Immunology, 139, 215-220.
4. Brindley, P. J. & Sher, A. (1990). Minireview: immunological involvement in the efficacy of praziquantel. Experimental Parasitology, 71, 245-248.
5. Butterworth, A. E., Sturrock, R. F., Ouma, J. H., Mbugua, G. G., Fulford, A. J. C., Kariuki, H. C. & Koech, D. (1991). Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. Parasitology, 103, 339-355.
6. Davis, A. (1993). Antischistosomal drugs and clinical practice. In: Human Schistosomiasis, Jordan, P.,Webbe, G. & Sturrock, R. F. (editors). Wallingford: CAB International, pp. 367-404.
7. De Clercq, D., Sacko, M., Behnke, J. M., Gilbert, F. S., Dorny, P. & Vercruysse, J. (1997). Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. American Journal of Tropical Medicine and Hygiene, 57, 25-30.
8. Doenhoff, M. J., Sabah, A. A., Fletcher, C., Webbe, G. & Bain, J. (1987). Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 947-951.
9. Fallon, P. G. & Doenhoff, M. K. (1994). Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. American Journal of Tropical Medicine and Hygiene, 51, 83-88.
10. Fallon, P. G., Sturrock, R. F., Capron, A., Niang, M. & Doenhoff, M. J. (1995). Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 53, 61-62.
11. Fallon, P. G., Tao, L.-F., Ismail, M. M. & Bennett J. L. (1996). Schistosome resistance to praziquantel: fact or artifact? Parasitology Today, 12, 316-320.
12. Geerts, S., Coles, G. C. & Gryseels, B. (1997). Anthelmintic resistance in human helminths: learning from the problems with worm control in livestock. Parasitology Today, 13, 149-151.
13. Gryseels, B. & de Vlas, S. J. (1996). Worm burdens in schistosome infections. Parasitology Today, 12, 115-119.
14. Gryseels, B., Nkulikyinka, L. & Coosemans, M. H. (1987). Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 641-644.
15. Guisse, F., Polman, K., Stelma, F. F., Mbaye, A., Talla, I., Niang, M., Deelder, A. M., Ndir, O. & Gryseels, B. (1997). Therapeutical evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal. American Journal of Tropical Medicine and Hygiene, 56, 511-514.
16. Ismail, M. M., Metwally, A., Farghaly, A., Bruce, J., Tao, L.-F. & Bennett, J. L. (1996). Characterization of isolates of Schistosoma mansoni from Egyptian villages that tolerate high doses of praziquantel. American Journal of Tropical Medicine and Hygiene, 55, 214-218.
17. Kardaman, M. W., Amin, M. A., Fenwick, A., Cheesmond, A. K. & Dixon, H. G. (1983). A field trial using praziquantel (Biltricide) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan. Annals of Tropical Medicine and Parasitology, 77, 297-304.
18. Katz, N., Rocha, R. S. & Chaves, A. (1979). Essais préliminaires avec le praziquantel dans les infections humaines à Schistosoma mansoni. Bulletin of the World Health Organization, 57, 781-784.
19. Picquet, M., Ernould, J. C., Vercruysse, J., Southgate, V. R., Mbaye, A., Sambou, B., Niang, M. & Rollinson, D. (1996). The epidemiology of human schistosomiasis in the Senegal river basin. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 340-346.
20. Polderman, A. M., Mpamila, K., Manshande, J. P. & Bouwhuis-Hoogerwerf, M. L. (1985). Methodology and interpretation of parasitological surveillance of intestinal schistosomiasis in Maniema, Kivu Province, Zaire. Annales de la Société Belge de Médecine Tropicale, 65, 243-249.
21. Polderman, A. M., Gryseels, B. & De Caluwé, P. (1988). Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 115-116.
22. Sabah, A. A., Fletcher, C., Webbe, G. & Doenhoff, M. J. (1986). Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology, 61, 294-303.
23. Shaw, M. K. (1990). Schistosoma mansoni: stage-dependent damage after in vivo treatment with praziquantel. Parasitology, 100, 65-72.
24. Stelma, F. F. (1997). Immuno-epidemiology, morbidity and chemotherapy in a community recently exposed to Schistosoma mansoni infection - a study in northern Senegal. PhD thesis, University of Leiden.
25. Stelma, F. F., Talla, I., Polman, K., Niang, M., Sturrock, R. F., Deelder, A. M. & Gryseels, B. (1993). Epidemiology of Schistosoma mansoni infection in a recently exposed community in northern Senegal. American Journal of Tropical Medicine and Hygiene, 49, 710-706.
26. Stelma. F. F., Talla, I., Sow, S., Kongs, A., Niang, M., Polman, K., Deelder, A. M. & Gryseels, B. (1995). Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. American Journal of Tropical Medicine and Hygiene, 53, 167-170.
27. WHO (1992). Praziquantel shows unexpected failure in recent schistosomiasis outbreak. TDR News, 41, 2-3.
28. WHO (1993). Praziquantel in Senegal schistosomiasis outbreak. TDR News, 42, 10-12.
29. Xiao, S. H., Catto, B. A. & Webster, L. T. (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases, 151, 1130-1137.